Invasive ductal carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia manifesting as a collision breast tumor: A case report and literature review.
SLL/CLL
breast carcinoma
collision tumor
invasive ductal carcinoma
lymphoma
Journal
Open life sciences
ISSN: 2391-5412
Titre abrégé: Open Life Sci
Pays: Poland
ID NLM: 101669614
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
05
2021
revised:
11
07
2021
accepted:
21
07
2021
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
16
9
2021
Statut:
epublish
Résumé
Collision breast tumors, consisting of breast cancer (BC) and non-Hodgkin's lymphoma (NHL), are extremely rare. Here we report the case of a 64-year-old woman with a collision tumor in her left breast mass that was composed of invasive ductal carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia. In addition, we reviewed the published comparable English-language literature. Collision breast tumor composed of BC and NHL is extremely rare. For that reason, there is a lack of consensus about the underlying mechanism, and diagnosing it without delay remains a complex clinical challenge. We found that post-menopausal, age-related estrogen levels changes and Epstein-Barr virus infection are possible pathogenic factors. However, the symptoms are almost identical, and it is difficult to distinguish a simple breast tumor from a breast collision tumor. In this study, we reviewed the clinical features of all patients with BC and NHL colliding breast tumors; this information might enable early identification and prevention of misdiagnosis.
Identifiants
pubmed: 34522780
doi: 10.1515/biol-2021-0093
pii: biol-2021-0093
pmc: PMC8402943
doi:
Types de publication
Case Reports
Langues
eng
Pagination
867-871Informations de copyright
© 2021 Xiaowen Chen et al., published by De Gruyter.
Déclaration de conflit d'intérêts
Conflict of interest: The authors state no conflict of interest.
Références
Breast J. 2007 Jul-Aug;13(4):413-7
pubmed: 17593048
Medicine (Baltimore). 2019 Sep;98(39):e17043
pubmed: 31574801
Exp Ther Med. 2020 Oct;20(4):3458-3461
pubmed: 32905114
Arch Pathol Lab Med. 2004 Jan;128(1):99-101
pubmed: 14692838
Anticancer Res. 2021 Jul;41(7):3639-3642
pubmed: 34230161
Indian J Med Paediatr Oncol. 2016 Jul-Sep;37(3):146-51
pubmed: 27688607
PLoS One. 2012;7(11):e48788
pubmed: 23183846
Front Oncol. 2017 May 26;7:110
pubmed: 28603694
J Surg Case Rep. 2016 Jan 22;2016(1):
pubmed: 26801778
J Labelled Comp Radiopharm. 2019 Oct;62(12):850-859
pubmed: 31461549
Leuk Lymphoma. 2013 Apr;54(4):720-5
pubmed: 22916741
Maturitas. 2011 Feb;68(2):129-36
pubmed: 21145188
Int J Surg Pathol. 2018 Jun;26(4):296-305
pubmed: 29320898
Clin Nucl Med. 2021 Apr 1;46(4):e214-e215
pubmed: 33208615
EBioMedicine. 2016 Jul;9:148-160
pubmed: 27333046
South Med J. 2006 Feb;99(2):164-7
pubmed: 16509555
J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):25-42
pubmed: 23392570
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1747-55
pubmed: 23885038
Clin Breast Cancer. 2015 Aug;15(4):e209-12
pubmed: 25818398
Cureus. 2020 Aug 28;12(8):e10104
pubmed: 33005523